OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
Jian Hu, Dongxu Qiu, Anze Yu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 147

Liquid–liquid phase separation in tumor biology
Xuhui Tong, Rong Tang, Jin Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 131

N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50

The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30

Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer
Xiaoqian Dong, Pan Liao, Xiaotong Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12915-12915
Open Access | Times Cited: 25

RNA-binding proteins in cancer drug discovery
Jean B. Bertoldo, Simon Müller, Stefan Hüttelmaier
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103580-103580
Closed Access | Times Cited: 22

Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets
Xin Niu, Lei Zhang, Yuchen Wu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 20

RNA m6Amethylation in cancer
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 27

Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers
Dazhao Peng, Cheng Wei, Xiaoyang Zhang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 28

GCH1 reduces LPS-induced alveolar macrophage polarization and inflammation by inhibition of ferroptosis
Yuhong Xiao, Ye Yuan, Yuhui Yang, et al.
Inflammation Research (2023) Vol. 72, Iss. 10-11, pp. 1941-1955
Closed Access | Times Cited: 12

RNA binding proteins in senescence: A potential common linker for age-related diseases?
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Annalisa Barbieri, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101958-101958
Closed Access | Times Cited: 11

Autophagy‐related CMTM6 promotes glioblastoma progression by activating Wnt/β‐catenin pathway and acts as an onco‐immunological biomarker
Lirui Dai, Jingjia Xiao, Xiang Li, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 5
Open Access | Times Cited: 4

USP18 Promotes Cholesterol Efflux and Mitigates Atherosclerosis by Deubiquitinating ABCG1
Yang An, Chunxian Guo, Xiaoli Wang, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access

HOXD8 Drives Glioma Progression through Epithelial-Mesenchymal Transition Regulation: Implications for Prognosis and Targeted Therapy
Ke Yu, Jiawei Meng, T Chen, et al.
Experimental Cell Research (2025), pp. 114476-114476
Closed Access

YTHDF1/RNF7/p27 axis promotes prostate cancer progression
Yulin Shi, Baiyang Liu, Yong Zhang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access

AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer
Yuling Zeng, Xueping Zhang, Fazhan Li, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 6
Open Access | Times Cited: 18

The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma
Fan Chen, Xuan Xie, Min Chao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17

Cationic Lipids‐Mediated Dual‐Targeting of Both Dendritic Cells and Tumor Cells for Potent Cancer Immunotherapy
Min Li, Han Zhou, Minghao Fang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 46
Closed Access | Times Cited: 10

Aspirin increases chemosensitivity of colorectal cancer cells and inhibits the expression of toll-like receptor 4
Jun Ying, Haiyang Zhou, Zhiguo Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top